Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β adrenoceptor mediated mechanism

British Journal of Pharmacology

Volumn 125, Issue 6, 1998, Pages 1297-1303

  Haskó, György ^b,c   Shanley, Thomas P ^a   Egnaczyk, Greg ^a   Németh, Zoltán H ^b   Salzman, Andrew L ^a   Vizi, E Sylvester ^b   Szabó, Csaba ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c INOTEK CORPORATION   (United States)

Author keywords

Adrenergic; Chemokines; Inflammation; Macrophage; Sympathetic nervous system

Indexed keywords

ADRENALIN; BACTERIUM LIPOPOLYSACCHARIDE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; ISOPRENALINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR; PROPRANOLOL; PROSTAGLANDIN E2; ROLIPRAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0031772806     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702179     Document Type: Article

References (47)

1. BESEDOVSKY, H.O. & DEL REY, A. (1996). Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev., 17, 64-102.
2. COOK, D.N., BECK, M.A., COFFMAN, T.M., KIRBY, S.L., SHERIDAN, J.F., PRAGNELL, I.B. & SMITHIES, O. (1995). Requirement of MIP-1α for an inflammatory response to viral infection. Science, 269, 1583-1585.
3. DAVATELIS, G., TEKAMP-OLSON, T., WOLPE, S.D., HERMSEN, K., LUEDKE, C., GALLEGOS, C., COIT, D., MERRYWEATHER, J. & CERAMI, A. (1988). Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J. Exp. Med., 167, 1939-1944.
4. DUNN, A.J. (1992). Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: Comparison with interleukin-1. J. Pharmacol. Exp. Ther., 261, 964-969.
5. ELENKOV, I.J., HASKÓ, G., KOVÁCS, K.J. & VIZI, E.S. (1995). Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J. Neuroimmunol., 61, 123-131.
6. ELENKOV, I.J., PAPANICOLAOU, D.A., WILDER, R.L. & CHROUSOS, G.P. (1996). Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. P. Assoc. Am. Physicians, 108, 374- 381.
7. FAHEY, T.J. III, TRACEY, K.J., TEKAMP-OLSON, P., COUSENS, L.S., JONES, W.G., SHIRES, G.T., CERAMI, A. & SHERRY, B. (1992). Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol., 148, 2764-2769.
8. FEINSTEIN, D.L., GALEA, E. & REIS, D.J. (1993). Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem., 60, 1945-1948.
9. HALL, R.C. & HODGE, R.L. (1971). Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs. J. Physiol., 213, 69-84.
10. HASKÓ, G. & SZABÓ, C. (1998). Regulation of cytokine and chemokine production by transmitters of the sympathetic nervous system. Biochem. Pharmacol., 56, 1079-1087.
11. HASKÓ, G., ELENKOV, I.J. & VIZI, E.S. (1995a). Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus. Immunol. Lett., 47, 133-137.
12. 2-adrenoreceptors on plasma levels of tumour necrosis factor-α, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J. Endocrinol., 144, 457-462.
13. HASKÓ, G., NÉMETH, Z.H., SZABÓ, C., ZSILLA, G., SALZMAN, A.L. & VIZI, E.S. (1998a). Isoproterenol inhibits IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages. Brain Res. Bull., 45, 183-187.
14. HASKÓ, G., SZABÓ, C., NÉMETH, Z.H., KVETAN, V., PASTORES, S.M. & VIZI, E.S. (1996). Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol., 157, 4634-4640.
15. HASKÓ, G., SZABÓ, C., NÉMETH, Z.H., SALZMAN, A.L. & VIZI, E.S. (1998b). Suppression of interleukin-12 production by phosphodiesterase inhibition in murine endotoxemia is interleukin-10 independent. Eur. J. Immunol., 28, 468-472.
16. HASKÓ, G., VIRÁG, L., EGNACZYK, G., SALZMAN A.L. & SZABÓ, C. (1998c). The crucial role of interleukin-10 in the suppression of the immune response in mice exposed to staphylococcal enterotoxin B. Eur. J. Immunol., 28, 1417-1425.
17. HU, X., GOLDMUNTZ, E.A. & BROSNAN, C.F. (1991). The effect of norepinephrine on endotoxin-mediated macrophage activation. J. Neuroimmunol., 31, 35-42.
18. IGNATOWSKY, T.A., GALLANT, S. & SPENGLER, R.N. (1996). Temporal regulation by adrenergic receptor stimulation of macrophage (Mφ)-derived tumor necrosis factor (TNF) production post-LPS challenge. J. Neuroimmunol., 65, 107-117.
19. KARPUS, W.J., LUKACS, N.W., McRAE, B.L. STRIETER, R.M., KUNKEL, S.L. & MILLER, S.D. (1995). An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol., 155, 5003-5010.
20. KASAMA, T., STRIETER, R.M., LUKACS, N.W., LINCOLN, P.M., BURDICK, M.D. & KUNKEL, S.L. (1995). Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest., 95, 2868-2876.
21. KASAMA, T., STRIETER, R.M., STANDIFORD, T.J., BURDICK, M.D. & KUNKEL S.L. (1993). Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1α. J. Exp. Med., 178, 63-72.
22. KOCH, A.E., KUNKEL, S.L., HARLOW, L.A., MAZARAKIS, D.D., HAINES, G.K., BURDICK, M.D., POPE, R.M. & STRIETER, R.M. (1994). Macrophage inflammatory protein-1α: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin. Invest., 93, 921-928.
23. KOFF, W.C. & DUNEGAN, M.A. (1985). Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immunol., 135, 350-354.
24. MADDEN, K.S., SANDERS, V.M. & FELTEN D.L. (1995). Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol., 35, 417-448.
25. MARTIN, C.A. & DORF, M.E. (1991). Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE MCP-1 cytokine expression in macrophage cell lines. Cell. Immunol., 135, 245-258.
26. NATORI, Y., SEKIGUCHI, M., OU, Z. & NATORI, Y. (1997). Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin. Exp. Immunol., 109, 143-148.
27. PASTORES, S.M., HASKO, G., VIZI, E.S. & KVETAN, V. (1996). The role of vasoactive drugs in the regulation of cytokine production in sepsis. New Horiz., 4, 252-264.
28. PICK, E. (1972). Cyclic AMP affects macrophage migration. Nature New Biol., 238, 176-177.
29. SANDERS, V.M. (1995). The role of adrenoceptor-mediated signals in the modulation of lymphocyte function. Adv. Neuroimmunol., 5, 283-298.
30. SCHALL, T.J., O'HEHIR, R.E., GOEDDEL, D.V. & LAMB, J.R. (1992). Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J. Immunol., 148, 381-387.
31. SEVERN, A., RAPSON, N.T., HUNTER, C.A. & LIEW, F.Y. (1992). Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol., 148, 3441-3445.
32. SHANLEY, T.P., SCHMAL, H., FRIEDL, H.P., JONES, M.L. & WARD, P.A. (1995). Role of macrophage inflammatory protein-1α (MIP-1α) in acute lung injury in rats. J. Immunol., 154, 4793-4802.
33. SHANLEY, T.P., SCHRIER, D., KAPUR, V., KEHOE, M., MUSSER, J.M. & WARD, P.A. (1996). Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect. Immun., 64, 870-877.
34. SPENGLER, R.N., ALLEN, R.M., REMICK, D.G., STRIETER, R.M. & KUNKEL, S.L. (1990). Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol., 145, 1430-1434.
35. SPENGLER, R.N., CHENSUE, S.W., GIACHERIO, D.A., BLENK, N. & KUNKEL, S.L. (1994). Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J. Immunol., 152, 3024-3031.
36. 2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor α gene expression. Infect. Immun., 57, 2837-2841.
37. STANDIFORD, T.J., KUNKEL, S.L., LUKACS, N.W., GREENBERGER, M.J., DANFORTH, J.M., KUNKEL, R.G. & STRIETER, R.M. (1995). Macrophage inflammatory protein-1α mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol., 155, 1515-1524.
38. STRIETER, R.M., STANDIFORD, T.J., HUFFNAGLE, G.B., COLLETTI, L.M., LUKACS, N.W. & KUNKEL, S.L. (1996). "The good, the bad, and the ugly": the role of chemokines in models of human disease. J. Immunol., 156, 3583-3586.
39. SZABÓ, C., HASKÓ, G., ZINGARELLI, B., NÉMETH, Z.H., SALZMAN, A.L., KVETAN, V., PASTORES, S.M. & VIZI, E.S. (1997). Isoproterenol regulates TNF, IL-10, IL-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxemia. Immunology, 90, 95-100.
40. TWENTYMAN, O.P., FINNERTY, J.P., HARRIS, A., PALMER, J. & HOLGATE, S.T. (1990). Protection against allergen-induced asthma by salmeterol. Lancet, 336, 1338-1342.
41. VAN DER POLL, T., COYLE, S.M., BARBOSA, K., BRAXTON, C.C. & LOWRY, S.F. (1996). Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest., 97, 713-719.
42. VAN DER POLL, T. & LOWRY, S.F. (1997). Lipopolysaccharideinduced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect. Immun., 65, 2378-2381.
43. VANOTTEREN, G.M., STANDIFORD, T.J., KUNKEL, S.L., DANFORTH, J.M., BURDICK, M.D., ABRUZZO, L.V. & STRIETER, R.M. (1994). Expression and regulation of macrophage inflammatory protein-1α by murine alveolar and peritoneal macrophages. Am. J. Respir. Cell Mol. Biol., 10, 8-15.
44. VERANI, A., SCARLATTI, G., COMAR, M., TRESOLDI, E., POLO, S., GIACCA, M., LUSSO, P. SICCARDI, A.G. & VERCELLI, D. (1997). C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med., 185, 805-816.
45. VIZI, E.S., ORSÓ, E., OSIPENKO, O.N., HASKÓ, G. & ELENKOV, I.J. (1995). Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience, 68, 1263-1276.
46. WIEGMANN, K., MUTHYALA, S., KIM, D.H., ARNASON, B.G.W. & CHELMICKA-SCHORR, E. (1995). β-Adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol., 56, 201-206.
47. WOLPE, S.D., DAVATELIS, G., SHERRY, B., BEUTLER, B., HESSE, D., NGUYEN, H., MOLDAWER, L.L., NATHAN, C.F., LOWRY, S.F. & CERAMI, A. (1988). Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J. Exp. Med., 167, 570-581.